Francesco Lanza

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 554 citations · Full text

Medicine, Hematology, Oncology +16

Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

Jakob Passweg, Helen Baldomero, Peter Bader et al. · Bone Marrow Transplantation · 2016 · 393 citations · Full text

Medicine, Hematology, Oncology +15

Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

Jakob Passweg, Helen Baldomero, Peter Bader et al. · Bone Marrow Transplantation · 2017 · 392 citations · Full text

Medicine, Hematology, Cell Therapy +10

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Adriano Venditti, Alfonso Piciocchi, Anna Candoni et al. · Blood · 2019 · 215 citations · Full text

Medicine, Internal Medicine, Oncology +8

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

Jakob Passweg, Helen Baldomero, Peter Bader et al. · Bone Marrow Transplantation · 2015 · 203 citations · Full text

Medicine, Hematology, Oncology +15